INSIGHTS ON LIQUID DOSE MANUFACTURING

  • Protecting Your Drug Product: Integrating Engineering And Quality
    8/31/2026

    Engineering decisions in fill/finish directly shape product quality and sterility assurance. This article examines how inert gas purging, plunger placement, dosing verification, and barrier systems interact across line design.

  • Spray Dried Biologics For Nasal Dosage Forms
    5/5/2026

    A fireside chat explores spray drying for nasal biologics, covering formulation science, particle design, delivery advantages, and testing strategies to move from concept to clinic.

  • Three Key Actions To Minimize Dead Volumes
    10/10/2025

    Minimizing liquid dead volume helps labs conserve costly reagents and scarce samples while boosting assay throughput. Learn how advanced liquid level detection technologies are driving efficiency.

  • Innovation In Filtration
    3/18/2025

    Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.

  • Maintaining Cell Viability During The Cryovial Filling Process
    4/21/2025

    Maintaining cell viability during cryovial filling is a critical challenge in cell therapy manufacturing. This presentation introduces cryoFIL®, a cutting-edge automated cryovial filling platform designed to deliver high-precision, aseptic, and scalable solutions for cryovial filling.

LIQUID DOSE MANUFACTURING SOLUTIONS

  • Streamline diagnostic manufacturing from initial laboratory testing through high-volume commercial production. Modular assembly platforms offer precise liquid dosing to ensure regulatory compliance.

  • Modular aseptic isolation combines sterility assurance, rapid bio-decontamination, glove and chamber leak testing, and validation-ready controls to support safer pharmaceutical and biotech production.

  • Aseptic fill‑finish services support parenteral drug products with advanced formulation development, scalable vial and prefilled syringe manufacturing, and integrated quality and regulatory support.

  • Dec’s ability to provide end-to-end solutions from API manufacturing to primary packaging filling covers the complete range from R&D processes and small batches to large filling campaigns. Our solutions include state of the art robotics for the filling and handling of complex delivery systems like pre-filled syringes (PFS).

  • Medicines are highly sensitive to primary packaging components, which can affect compatibility with container closure systems. Discover Alba® syringes, designed for sensitive biologics, including highly concentrated drugs vulnerable to silicone interaction and ophthalmic medications.